Langerhans cell histiocytosis and Erdheim-Chester disease, a continuity?

被引:4
作者
Parreau, S. [1 ]
Haroche, J. [2 ]
Pommepuy, I. [3 ]
Emile, J. F. [4 ,5 ]
Bourras, J. C. [6 ]
Archambeaud, F. [1 ]
机构
[1] Hop Cluzeau, Serv Endocrinol, 23 Ave Dominique Larrey, F-87042 Limoges, France
[2] Hop La Pitie Salpetriere, AP HP, Serv Pathol, F-75013 Paris, France
[3] Hop Univ Limoges, Serv Anatomopathol, 2 Ave Matin Luther King, F-87000 Limoges, France
[4] Univ Paris Saclay, Univ Versailles, EA4340, Biomarqueurs Cancerol & Oncohematol 7, F-78035 Versailles, France
[5] Univ Paris 06, UMPC, Grp Hosp Pitie Salpetriere, AP HP,Serv Med Interne 2,Ctr Natl Reference Malad, 47-83 Blvd Hop, F-75651 Paris, France
[6] Clin Francois Chenieux, Serv Radiol, 18 Rue Gen Catroux, F-87039 Limoges, France
来源
REVUE DE MEDECINE INTERNE | 2017年 / 38卷 / 07期
关键词
Erdheim-Chester disease; Langerhans cell histiocytosis; BRAF; Vemurafenib; HIGH PREVALENCE; MUTATIONS; MANIFESTATIONS;
D O I
10.1016/j.revmed.2016.10.389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Erdheim-Chester disease and langerhans cell histiocytosis are two rare diseases separate on clinical, radiological and histological aspects. However, several cases involving both entities have been described. Observation. A 70-year-old man had a central diabetes insipidus, xanthelasmas, retroperitoneal fibrosis and osteosclerosis of the legs suggestive of Erdheim-Chester disease. Bone biopsy showed langerhans cell histiocytosis CD1a positive with the presence of BRAF V600E mutation. The patient was treated with vemurafenib with a good clinical course. Conclusion. The literature review finds forty observations linking the two diseases that may suggest a pathophysiological link, especially with the hematopoietic myeloid stem cell CD34(+). The term inflammatory myeloid neoplasm was advanced. (C) 2016 Societe Nationale Frangaise de Medecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:482 / 487
页数:6
相关论文
共 32 条
[1]   Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease [J].
Aouba, Achille ;
Georgin-Lavialle, Sophie ;
Pagnoux, Christian ;
Silva, Nicolas Martin ;
Renand, Amedee ;
Galateau-Salle, Francoise ;
Le Toquin, Sophie ;
Bensadoun, Henri ;
Larousserie, Frederique ;
Silvera, Stephane ;
Provost, Nicole ;
Candon, Sophie ;
Seror, Raphaele ;
de Menthon, Mathilde ;
Hermine, Olivier ;
Guillevin, Loic ;
Bienvenu, Boris .
BLOOD, 2010, 116 (20) :4070-4076
[2]   CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients [J].
Arnaud, Laurent ;
Hervier, Baptiste ;
Neel, Antoine ;
Hamidou, Mohamed A. ;
Kahn, Jean-Emmanuel ;
Wechsler, Bertrand ;
Perez-Pastor, Gemma ;
Blomberg, Bjorn ;
Fuzibet, Jean-Gabriel ;
Dubourguet, Francois ;
Marinho, Antonio ;
Magnette, Catherine ;
Noel, Violaine ;
Pavic, Michel ;
Casper, Jochen ;
Beucher, Anne-Berangere ;
Costedoat-Chalumeau, Nathalie ;
Aaron, Laurent ;
Salvatierra, Juan ;
Graux, Carlos ;
Cacoub, Patrice ;
Delcey, Veronique ;
Dechant, Claudia ;
Bindi, Pascal ;
Herbaut, Christiane ;
Graziani, Giorgio ;
Amoura, Zahir ;
Haroche, Julien .
BLOOD, 2011, 117 (10) :2778-2782
[3]   Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? [J].
Berres, Marie-Luise ;
Merad, Miriam ;
Allen, Carl E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (01) :3-13
[4]  
Boralevi F, 1998, ANN DERMATOL VENER, V125, P335
[5]   High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis [J].
Brown, Noah A. ;
Furtado, Larissa V. ;
Betz, Bryan L. ;
Kiel, Mark J. ;
Weigelin, Helmut C. ;
Lim, Megan S. ;
Elenitoba-Johnson, Kojo S. J. .
BLOOD, 2014, 124 (10) :1655-1658
[6]   Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease [J].
Emile, Jean-Francois ;
Diamond, Eli L. ;
Helias-Rodzewicz, Zofia ;
Cohen-Aubart, Fleur ;
Charlotte, Frederic ;
Hyman, David M. ;
Kim, Eunhee ;
Rampal, Raajit ;
Patel, Minal ;
Ganzel, Chezi ;
Aumann, Shlomzion ;
Faucher, Gladwys ;
Le Gall, Catherine ;
Leroy, Karen ;
Colombat, Magali ;
Kahn, Jean-Emmanuel ;
Trad, Salim ;
Nizard, Philippe ;
Donadieu, Jean ;
Taly, Valerie ;
Amoura, Zahir ;
Abdel-Wahab, Omar ;
Haroche, Julien .
BLOOD, 2014, 124 (19) :3016-3019
[7]   BRAF Mutations in Erdheim-Chester Disease [J].
Emile, Jean-Francois ;
Charlotte, Frederic ;
Amoura, Zahir ;
Haroche, Julien .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :398-398
[8]  
Emile JF, 2016, PRESSE MED
[9]   Erdheim-Chester disease [J].
Haroche, J. ;
Cohen-Aubart, F. ;
Arnaud, L. ;
Hervier, B. ;
Charlotte, F. ;
Drier, A. ;
Gorochov, G. ;
Grenier, P. A. ;
Cluzel, P. ;
Maksud, P. ;
Emile, J. -F. ;
Amoura, Z. .
REVUE DE MEDECINE INTERNE, 2014, 35 (11) :715-722
[10]  
Haroche J, 2016, PRESSE MED